Published in Am J Obstet Gynecol on May 01, 2002
Perinatal Outcome of the Second Twin at a Tertiary Care Center in India. J Obstet Gynaecol India (2015) 0.75
Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06
Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med (2009) 6.86
Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol (2006) 3.15
Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med (2002) 2.78
Urinary placental growth factor and risk of preeclampsia. JAMA (2005) 2.76
Fetal injury associated with cesarean delivery. Obstet Gynecol (2006) 2.61
Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension (2009) 2.51
Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol (2008) 2.21
Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol (2007) 2.19
Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol (2006) 2.15
Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am J Epidemiol (2003) 1.91
Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol (2002) 1.70
Prediction of uterine rupture associated with attempted vaginal birth after cesarean delivery. Am J Obstet Gynecol (2008) 1.70
Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol (2004) 1.69
Prediction and prevention of recurrent preeclampsia. Obstet Gynecol (2008) 1.66
Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol (2006) 1.65
Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol (2008) 1.59
Timing of elective repeat cesarean delivery at term and maternal perioperative outcomes. Obstet Gynecol (2011) 1.54
The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. Am J Obstet Gynecol (2005) 1.54
Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol (2007) 1.52
Maternal obesity, uterine activity, and the risk of spontaneous preterm birth. Obstet Gynecol (2009) 1.49
Risk of uterine rupture and adverse perinatal outcome at term after cesarean delivery. Obstet Gynecol (2007) 1.42
Comparison of transverse and vertical skin incision for emergency cesarean delivery. Obstet Gynecol (2010) 1.39
Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol (2007) 1.38
Outcomes of induction of labor after one prior cesarean. Obstet Gynecol (2007) 1.34
Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol (2002) 1.33
Postpartum headache: is your work-up complete? Am J Obstet Gynecol (2007) 1.27
Failed operative vaginal delivery. Obstet Gynecol (2009) 1.27
Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol (2005) 1.26
Comparison of maternal and infant outcomes from primary cesarean delivery during the second compared with first stage of labor. Obstet Gynecol (2007) 1.24
Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol (2003) 1.17
Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol (2011) 1.16
Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol (2005) 1.16
Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol (2002) 1.15
Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet Gynecol (2007) 1.13
Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol (2004) 1.11
Indications for delivery and short-term neonatal outcomes in late preterm as compared with term births. Am J Obstet Gynecol (2009) 1.09
The MFMU Cesarean Registry: impact of time of day on cesarean complications. Am J Obstet Gynecol (2006) 1.09
Antioxidant supplementation and premature rupture of the membranes: a planned secondary analysis. Am J Obstet Gynecol (2008) 1.08
Blood transfusion and cesarean delivery. Obstet Gynecol (2006) 1.08
Less-tight versus tight control of hypertension in pregnancy. N Engl J Med (2015) 1.07
Maternal and neonatal outcomes of repeat cesarean delivery in women with a prior classical versus low transverse uterine incision. Am J Perinatol (2010) 1.07
Preeclampsia: Diagnosis and management of the atypical presentation. J Matern Fetal Neonatal Med (2006) 1.06
Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol (2005) 1.06
Severe sepsis and septic shock in pregnancy. Obstet Gynecol (2012) 1.05
The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol (2005) 1.02
Can a prediction model for vaginal birth after cesarean also predict the probability of morbidity related to a trial of labor? Am J Obstet Gynecol (2008) 1.02
Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol (2007) 1.00
The frequency and complication rates of hysterectomy accompanying cesarean delivery. Obstet Gynecol (2009) 1.00
Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery. Obstet Gynecol (2009) 1.00
Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol (2004) 0.99
Does information available at admission for delivery improve prediction of vaginal birth after cesarean? Am J Perinatol (2009) 0.97
Expectant management in pregnancies with severe pre-eclampsia. Semin Perinatol (2009) 0.97
Previous preterm cesarean delivery and risk of subsequent uterine rupture. Obstet Gynecol (2008) 0.96
The MFMU Cesarean Registry: impact of fetal size on trial of labor success for patients with previous cesarean for dystocia. Am J Obstet Gynecol (2006) 0.96
Acute fatty liver of pregnancy associated with pancreatitis: a life-threatening complication. Am J Obstet Gynecol (2004) 0.95
Labor outcomes with increasing number of prior vaginal births after cesarean delivery. Obstet Gynecol (2008) 0.95
Measuring outpatient outcomes of emesis and nausea management in pregnant women. Manag Care (2004) 0.94
Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am J Obstet Gynecol (2002) 0.94
Seizures in pregnancy: epilepsy, eclampsia, and stroke. Semin Perinatol (2013) 0.94
Does peripartum infection increase the incidence of cerebral palsy in extremely low birthweight infants? Am J Obstet Gynecol (2007) 0.93
Timing of delivery and adverse outcomes in term singleton repeat cesarean deliveries. Obstet Gynecol (2013) 0.92
Elective repeat cesarean delivery compared with spontaneous trial of labor after a prior cesarean delivery: a propensity score analysis. Am J Obstet Gynecol (2012) 0.92
Elective delivery at 34⁰(/)⁷ to 36⁶(/)⁷ weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension. Am J Obstet Gynecol (2011) 0.91
Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. Obstet Gynecol (2006) 0.91
Use and misuse of the term "elective" in obstetrics. Obstet Gynecol (2011) 0.90
Increased risk of preeclampsia among nulliparous pregnant women with idiopathic hematuria. Am J Obstet Gynecol (2002) 0.89
Maternal and uteroplacental hemodynamics for the classification and prediction of preeclampsia. Hypertension (2008) 0.88
Mirror syndrome: a novel approach to therapy with fetal peritoneal-amniotic shunt. Obstet Gynecol (2007) 0.87
Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo. Am J Obstet Gynecol (2008) 0.87
Severe sepsis and septic shock in pregnancy: indications for delivery and maternal and perinatal outcomes. J Matern Fetal Neonatal Med (2012) 0.86
Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies? Hypertension (2005) 0.86
Second-trimester asynchronous multifetal delivery results in poor perinatal outcome. Obstet Gynecol (2004) 0.85
Preeclampsia: an inflammatory syndrome? Am J Obstet Gynecol (2004) 0.85
Chronic Hypertension in Pregnancy: Diagnosis, Management, and Outcomes. Clin Obstet Gynecol (2017) 0.84
Does progesterone treatment influence risk factors for recurrent preterm delivery? Obstet Gynecol (2005) 0.84
The Maternal-Fetal Medicine Unit cesarean registry: trial of labor with a twin gestation. Am J Obstet Gynecol (2005) 0.83
Intergenerational factors: a missing link for preeclampsia, fetal growth restriction, and cardiovascular disease? Hypertension (2008) 0.83
Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol (2005) 0.83
The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women. Am J Obstet Gynecol (2007) 0.83
Expectant management of severe preeclampsia: proper candidates and pregnancy outcome. Clin Obstet Gynecol (2005) 0.83
Cost-effectiveness of trial of labor after previous cesarean in a minimally biased cohort. Am J Perinatol (2013) 0.83
Modifiable risk factors for growth restriction in twin pregnancies. Am J Obstet Gynecol (2005) 0.83
Cervical dilatation on presentation for preterm labor and subsequent preterm birth. Am J Perinatol (2008) 0.83
Mode of delivery in women with antepartum fetal death and prior cesarean delivery. Am J Perinatol (2010) 0.82
Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter? Am J Obstet Gynecol (2007) 0.82
Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. Am J Obstet Gynecol (2003) 0.82
Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol (2011) 0.82
The coexistence of gestational hypertension and diabetes: influence on pregnancy outcome. Am J Perinatol (2008) 0.82
Heat shock protein 70 is not increased in women with severe preeclampsia. Hypertens Pregnancy (2002) 0.82
A system dynamics approach for healthcare waste management: a case study in Istanbul Metropolitan City, Turkey. Waste Manag Res (2012) 0.82
Lifetime cost-effectiveness of trial of labor after cesarean in the United States. Value Health (2013) 0.81